FDA Consumer

View more issues:

Articles in July-August, 2004 issue of FDA Consumer

• New risk information on IBS drug Zelnorm
• Flu vaccine and young children
• Truth in advertising: Rx drug ads come of age
  by Carol Rados
• New treatment for people with Parkinson's
• Study: U.S. generic drugs cost less than Canadian drugs
  by Linda Bren
• Lead contamination in candy
• Is your pet itching for relief?
  by Linda Bren
• New foodborne illness guide
• Consumer alert on Children's Motrin
• Preventing serious drug interactions
  by Michelle Meadows
• NIH, FDA launch new gene therapy research system
• New rules increase the safety of OTC ingredients
• Atherosclerosis linked to depression in older people
• Homemade ice cream: a safe summertime treat?
  by Linda Bren
• Observations
  by Raymond Formanek, Jr.
• New approval requirement for pancreatic drugs
• Ensuring the safety of dietary supplements
  by Michelle Meadows
• Drug combination can extend life for men with prostate cancer
• Drug maker to pay $430 million in fines, civil damages
• FDA.gov
  by John Henkel
• Final rule on detaining suspect food
• Diabetes prevention, treatment
  by Linda Bren
• New surgeon general's report expands list of smoking-related diseases
• Insulin for dogs with diabetes
• Physician sentenced for fraud
• Take the FDA consumer quiz
• Some questions and answers on prescription drug advertising
  by Amie C. Braman
• First-of-its-kind rapid HIV test kit approved
• New drug for bone marrow disease
  by Zacitidine